| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000011047 |
| Receipt No. | R000012238 |
| Official scientific title of the study | Study on the positive rate of skin prick test to the secreted protein of Malassezia |
| Date of disclosure of the study information | 2013/07/01 |
| Last modified on | 2017/03/07 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Study on the positive rate of skin prick test to the secreted protein of Malassezia | |
| Title of the study (Brief title) | Skin prick test to the secreted protein of Malassezia | |
| Region |
|
|
| Condition | |||
| Condition | Atopic dermatitis | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the positive rate of skin prick test to the secreted protein of Malassezia in patients with atopic dermatitis and healthy controls |
| Basic objectives2 | Others |
| Basic objectives -Others | positive rate of skin prick test |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Wheal and erythema induced by skin prick test to the purified-secreted protein of Malassezia |
| Key secondary outcomes | Estimate of safety of skin prick test. anaphylaxis after 15 min of SPT, and itch, exacerbation of eczema, late-phase skin induration, secondary infection |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Skin prick test (once) of the secreted protein of Malassezia | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (a) Subject is the age of 20 or older.
(b) Subject visits our outpatient clinic. (c) Subject is a healthy volunteer or a patient with atopic dermatitis. (d) Subject provides written informed consent. |
|||
| Key exclusion criteria | (a) Subject cannot stop antihistamine for two days.
(b) Subject is pregnant or possibly pregnant. (c) Subject is excluded by a primary doctor. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Michihiro Hide |
| Organization | Hiroshima University |
| Division name | Department of Dermatology |
| Address | 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan |
| TEL | 082-257-5237 |
| ed1h-w1de-road@hiroshima-u.ac.jp | |
| Public contact | |
| Name of contact person | Takaaki Hiragun |
| Organization | Hiroshima University |
| Division name | Department of Dermatology |
| Address | 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan |
| TEL | 082-257-5237 |
| Homepage URL | |
| hiragunt@hiroshima-u.ac.jp | |
| Sponsor | |
| Institute | Department of Dermatology, Integrated Health Sciences, Institute of Biomedical and Health Sciences, Hiroshima University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Dermatology, Integrated Health Sciences, Institute of Biomedical and Health Sciences, Hiroshima University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 広島大学病院(広島県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012238 |